|
Important research is under way with the goal of improving treatment options for patients with colorectal cancer. There is a clinical trial being conducted around the country to investigate a potential new colorectal cancer treatment. The study, known as PACCE (Panitumumab Advanced Colorectal Cancer Evaluation), is a Phase 3 clinical trial designed to evaluate the effects of using two targeted cancer therapies in combination with chemotherapy for patients with colorectal cancer that has spread.
Across the country, institutions are currently enrolling patients in the PACCE trial, and there may be a trial site in your area. The treatments used in the study are chemotherapy, which kills cancer cells; a medication called bevacizumab, approved to stop the growth of blood vessels to the tumor; and panitumumab, an experimental treatment that is being investigated to see if it will help stop the tumor from growing. Patients who participate in the trial are treated either with chemotherapy and bevacizumab, or with panitumumab in addition to chemotherapy and bevacizumab.
If you are 18 years of age or older, have been diagnosed with colorectal
cancer that has spread and would like additional information about the PACCE
trial, visit www.amgentrials.com or call (866) 57AMGEN (866-572-6436).
|
|
SIGN
UP FOR FREE
